Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
I just noticed that food sector stocks are becoming a major focus in the Thai and international stock markets, which is quite reasonable because food products are something people need to consume all the time, regardless of whether the economy is good or bad.
The food and pharmaceutical stock markets are stable and popular among fundamental investors because they have clear brands and relatively steady cash flows. In this regard, I want to share an analysis of 8 leading stocks to watch for growth beyond 2025.
Starting with Thai food stocks, Charoen Pokphand (CPF) is a leader in a comprehensive industry, operating in over 17 countries and exporting to more than 40 countries. The current price is 22.0 baht, with a P/E ratio of 11.9 times. Thai Union (TU) is also an interesting competitor, a global leader in seafood, expanding strategies in America and Europe, priced at 12.40 baht.
Asian Sea (ASIAN) is not to be missed, as the largest processed seafood producer in Thailand, priced at 7.85 baht, with a yield of 9.29%. Meanwhile, Minor Food (MINT), which expanded from restaurants to a large network, is priced at 22.0 baht, with a P/E of 42.7 times.
Looking at foreign food stocks, Nestlé (NESN), the world's largest food company founded in 1866, now has products in over 190 countries. It is priced at 74.04 Swiss francs, with a P/E ratio of 17.28 times. Coca-Cola (KO), also a major player, founded in 1886, owns over 200 brands in more than 200 countries, priced at $25.37. Pepsi (PEP), not just a beverage company, resulted from a merger with Frito-Lay, priced at $142.64. Unilever (UL), formed from the merger of several major brands, is priced at $55.13.
Health and wellness food and drug stocks present another big opportunity: Beyond Meat (BYND), a leader in plant-based protein foods; Oatly (OTLY), famous for oat milk; Tattooed Chef (TTCF), focusing on healthy ready-to-eat foods; Hain Celestial (HAIN), with organic products; Danone (DANOY), a leader in dairy and plant-based beverages; Nomad Foods (NOMD), specializing in premium frozen foods; Sprouts Farmers Market (SFM), a health-focused supermarket chain; and Ingredion (INGR), which specializes in food ingredients.
The advantages of investing in food and pharmaceutical stocks are clear: first, the demand for food remains relatively stable and continuous; second, these companies have stable cash flows and high profitability; third, ongoing innovation responds to changing consumption patterns, such as plant-based meats or low-sugar products; and fourth, many food companies pay stable and reliable dividends.
However, risks should also be considered: an economic slowdown could impact consumer spending; intense competition in the market; rising costs due to inflation; and rapid changes in consumer preferences.
If you want to invest in food and drug stocks, there are various methods, such as buying stocks directly through a securities account, investing via mutual funds, or using leveraged CFDs. But it’s essential to thoroughly study each company's fundamentals, such as revenue growth rates, net profit margins, and dividend-paying ability before making an investment decision.